Literature DB >> 10572980

Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.

S A Reuschel1, D Eades, R L Foltz.   

Abstract

The detection of LSD use continues to be a challenge for toxicology laboratories due to the very low concentrations of LSD and its metabolites in body fluids. However, significant progress has been made in the development of more sensitive and specific analytical methods. Techniques that have proven particularly effective include: (1) immunoaffinity extraction, (2) gas chromatography coupled with chemical ionization and tandem mass spectrometric detection, and (3) liquid chromatography in combination with electrospray ionization and either single-stage or tandem mass spectrometric detection. In addition, a major metabolite of LSD, 2-oxo-3-hydroxy-LSD, has been identified and found to be present in far higher concentrations than LSD in most LSD-positive urine samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572980     DOI: 10.1016/s0378-4347(99)00189-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  7 in total

Review 1.  Modern instrumental methods in forensic toxicology.

Authors:  Michael L Smith; Shawn P Vorce; Justin M Holler; Eric Shimomura; Joe Magluilo; Aaron J Jacobs; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-06       Impact factor: 3.367

2.  Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Angela Gasse; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2012-11-27       Impact factor: 2.686

Review 3.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

Review 4.  Analysis of Ergot Alkaloids.

Authors:  Colin Crews
Journal:  Toxins (Basel)       Date:  2015-06-03       Impact factor: 4.546

5.  Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.

Authors:  Patrick C Dolder; Yasmin Schmid; Manuel Haschke; Katharina M Rentsch; Matthias E Liechti
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-24       Impact factor: 5.176

6.  A Targeted UHPLC-MS/MS Method Validated for the Quantification of Ergot Alkaloids in Cereal-Based Baby Food from the Belgian Market.

Authors:  Bart Huybrechts; Svetlana V Malysheva; Julien Masquelier
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

7.  LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor.

Authors:  Donata Favretto; Giampietro Frison; Sergio Maietti; Santo Davide Ferrara
Journal:  Int J Legal Med       Date:  2006-02-23       Impact factor: 2.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.